Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution — FDA Drug Shortage

To Be Discontinued — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on Aug 31, 2026.

Shortage details

Status
To Be Discontinued
Company
Fresenius Kabi USA, LLC
Package NDC
65219-258-10
Dosage Form
Injection
Presentation
Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10)
Initial Posting
Aug 31, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.